Trial intelligence / Profile preview

Vitamin D3 for Painful Diabetic Neuropathy

NCT05080530Unknown

Sponsor
Baqai Institute of Diabetology and Endocrinology
Start
Oct 2021
Primary completion
Aug 2022
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, open-label trial of vitamin d in diabetic neuropathy (4 arms), sponsored by Baqai Institute of Diabetology and Endocrinology. Primary endpoints: Douleur Neuropathique 4 Score at 3 months, Glycated Hemoglobin at 3 months and 1 more. Status: unknown.

02

Drugs

vitamin d
03

Conditions

diabetic neuropathy

Beyond the preview

Go deeper on NCT05080530.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05080530.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call